Nasdaq · CIK 0001368514
ADMA ADMA BIOLOGICS, INC.
Insider trading from SEC Form 4. Last filing May 28, 2026. Close $10.36 on Oct 9, 2026, +36% from the 52-week low and -49% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company
Price and insider trades, last year
ADMAOct 9, 2026 · close 10.36
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at ADMA BIOLOGICS, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 45Moderate | Jerrold B Grossman director buy | $51k 6,400 shares | +1% | +1% from low-64% from high | |
| 48Moderate | Jerrold B Grossman director buy | $100k 12,500 shares | +2% | +7% from low-62% from high | |
| 43Moderate | Jerrold B Grossman director buy | $100k 12,500 shares | +3% | 0% from low-64% from high | |
| 12Weak | Adam S Grossman President and CEO sell | $318k 21,000 shares | -1% | +13% from low-35% from high | |
| 24Weak | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance sell | $158k 10,096 shares | -2% | +13% from low-36% from high | |
| 30Weak | Steve Elms director buy | $217k 14,000 shares | +1% | +12% from low-36% from high | |
| 5Weak | Adam S Grossman President and CEO sell | $338k 21,000 shares | -1% | +14% from low-35% from high | |
| 6Weak | Adam S Grossman President and CEO sell | $416k 21,000 shares | -1% | +41% from low-20% from high | |
| 5Weak | Adam S Grossman President and CEO sell | $336k 21,000 shares | -1% | +14% from low-35% from high | |
| 5Weak | Adam S Grossman President and CEO sell | $336k 21,000 shares | -1% | +9% from low-38% from high | |
| 5Weak | Adam S Grossman President and CEO sell | $339k 21,000 shares | -1% | 0% from low-38% from high | |
| 5Weak | Adam S Grossman President and CEO sell | $354k 21,000 shares | -1% | +10% from low-31% from high | |
| 6Weak | Adam S Grossman President and CEO sell | $392k 21,000 shares | -1% | +16% from low-27% from high | |
| 22Weak | Adam S Grossman President and CEO sell | $437k 21,000 shares | -1% | +32% from low-17% from high | |
| 45Moderate | Steve Elms director sell | $8.8M 425,621 shares | -20% | +40% from low-12% from high | |
| 51Moderate | Lawrence P. Guiheen director sell | $419k 20,000 shares | -17% | +35% from low-15% from high | |
| 27Weak | Jerrold B Grossman director sell | $213k 10,000 shares | -2% | +35% from low-15% from high | |
| 20Weak | Lawrence P. Guiheen director sell | $183k 9,000 shares | -7% | +30% from low-18% from high | |
| 14Weak | Adam S Grossman President and CEO sell | $408k 21,000 shares | -1% | +24% from low-22% from high | |
| 7Weak | Adam S Grossman President and CEO sell | $451k 21,000 shares | -1% | +43% from low-2% from high | |
| 6Weak | Adam S Grossman President and CEO sell | $397k 21,000 shares | -1% | +33% from low-9% from high | |
| 58Moderate | Adam S Grossman President and CEO sell | $1.0M 48,967 shares | -2% | - | |
| 44Moderate | Brad L. Tade CFO and Treasurer sell | $317k 15,000 shares | -7% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Nov 22, 2024 | Tade Brad L. Officer | 15,000 0.01% of outstanding | $320k | Nov 22, 2024 | none |
| Nov 22, 2024 | Grossman Adam S Director and Officer | 48,967 0.02% of outstanding | $1.0M | Nov 22, 2024 | $11M |
Transactions
The last 100 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | Jerrold B Grossman director | POpen-market purchase Common Stock | +6,400 | $7.91 | $51k | 520,284 | May 28, 2026 |
| May 12, 2026 | Jerrold B Grossman director | POpen-market purchase Common Stock | +12,500 | $8.01 | $100k | 513,884 | May 14, 2026 |
| May 11, 2026 | Jerrold B Grossman director | POpen-market purchase Common Stock | +12,500 | $8.01 | $100k | 501,384 | May 12, 2026 |
| Apr 1, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | FTax withholding Common Stock | -20,362 | $9.11 | $185k | 446,238 | Apr 3, 2026 |
| Mar 13, 2026 | Lawrence P. Guiheen director | MOption exercise Common Stock | +30,000 | $3.66 | $110k | 135,520 | Mar 17, 2026 |
| Mar 16, 2026 | Adam S Grossman President and CEO | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,133,777 | Mar 17, 2026 |
| Mar 16, 2026 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -15,000 | $15.16 | $227k | 2,118,777 | Mar 17, 2026 |
| Mar 17, 2026 | Lawrence P. Guiheen director | GGift Common Stock | -30,000 | $0.00 | $0 | 105,520 | Mar 17, 2026 |
| Mar 16, 2026 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -6,000 | $15.16 | $91k | 2,112,777 | Mar 17, 2026 |
| Mar 17, 2026 | Lawrence P. Guiheen director | GGift Common Stockindirect: See footnote | +30,000 | $0.00 | $0 | 30,000 | Mar 17, 2026 |
| Mar 13, 2026 | Lawrence P. Guiheen director | MOption exercise Stock Option (Right to Buy)derivative | -30,000 | $0.00 | $0 | 23,837 | Mar 17, 2026 |
| Mar 16, 2026 | Adam S Grossman President and CEO | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 690,950 | Mar 17, 2026 |
| Mar 6, 2026 | Adam S Grossman President and CEO | FTax withholding Common Stock | -56,438 | $15.39 | $869k | 2,148,290 | Mar 10, 2026 |
| Mar 6, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | FTax withholding Common Stock | -10,059 | $15.39 | $155k | 562,101 | Mar 10, 2026 |
| Mar 7, 2026 | Adam S Grossman President and CEO | FTax withholding Common Stock | -29,513 | $15.39 | $454k | 2,118,777 | Mar 10, 2026 |
| Mar 7, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | FTax withholding Common Stock | -4,235 | $15.39 | $65k | 557,866 | Mar 10, 2026 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | JOther Common Stock | -91,266 | $0.00 | $0 | 466,600 | Mar 10, 2026 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | MOption exercise Common Stock | +2,500 | $5.00 | $13k | 469,100 | Mar 10, 2026 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | MOption exercise Common Stock | +1,250 | $4.31 | $5,388 | 470,350 | Mar 10, 2026 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | MOption exercise Common Stock | +2,646 | $2.83 | $7,488 | 472,996 | Mar 10, 2026 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | MOption exercise Common Stock | +1,525 | $2.35 | $3,584 | 474,521 | Mar 10, 2026 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | MOption exercise Common Stock | +2,175 | $1.55 | $3,371 | 476,696 | Mar 10, 2026 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | SOpen-market sale Common Stock | -10,096 | $15.63 | $158k | 466,600 | Mar 10, 2026 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | MOption exercise Stock Option (right to buy)derivative | -2,500 | $0.00 | $0 | 2,500 | Mar 10, 2026 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | MOption exercise Stock Option (right to buy)derivative | -1,250 | $0.00 | $0 | 1,250 | Mar 10, 2026 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | MOption exercise Stock Option (right to buy)derivative | -2,646 | $0.00 | $0 | 2,771 | Mar 10, 2026 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | MOption exercise Stock Option (right to buy)derivative | -1,525 | $0.00 | $0 | 2,225 | Mar 10, 2026 |
| Mar 9, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | MOption exercise Stock Option (right to buy)derivative | -2,175 | $0.00 | $0 | 2,825 | Mar 10, 2026 |
| Mar 5, 2026 | Steve Elms director | POpen-market purchase Common Stockindirect: See footnote | +7,000 | $15.67 | $110k | 2,038,730 | Mar 9, 2026 |
| Mar 6, 2026 | Steve Elms director | POpen-market purchase Common Stockindirect: See footnote | +7,000 | $15.39 | $108k | 2,045,730 | Mar 9, 2026 |
| Feb 26, 2026 | Adam S Grossman President and CEO | FTax withholding Common Stock | -54,858 | $15.18 | $833k | 2,204,728 | Mar 2, 2026 |
| Feb 19, 2026 | Brad L. Tade CFO and Treasurer | FTax withholding Common Stock | -6,479 | $16.32 | $106k | 232,940 | Feb 23, 2026 |
| Feb 19, 2026 | Adam S Grossman President and CEO | FTax withholding Common Stock | -24,793 | $16.32 | $405k | 2,259,586 | Feb 23, 2026 |
| Feb 19, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | FTax withholding Common Stock | -8,161 | $16.32 | $133k | 572,160 | Feb 23, 2026 |
| Feb 17, 2026 | Adam S Grossman President and CEO | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,305,379 | Feb 17, 2026 |
| Feb 17, 2026 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -15,000 | $16.08 | $241k | 2,290,379 | Feb 17, 2026 |
| Feb 17, 2026 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -6,000 | $16.08 | $96k | 2,284,379 | Feb 17, 2026 |
| Feb 17, 2026 | Adam S Grossman President and CEO | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 705,950 | Feb 17, 2026 |
| Feb 9, 2026 | Steve Elms director | AGrant or award Common Stock | +10,690 | $0.00 | $0 | 98,020 | Feb 11, 2026 |
| Feb 9, 2026 | Lawrence P. Guiheen director | AGrant or award Common Stock | +10,690 | $0.00 | $0 | 105,520 | Feb 11, 2026 |
| Feb 9, 2026 | Eduardo Rene Salas director | AGrant or award Common Stock | +10,690 | $0.00 | $0 | 21,579 | Feb 11, 2026 |
| Feb 9, 2026 | Alison Cecily Finger director | AGrant or award Common Stock | +10,690 | $0.00 | $0 | 45,619 | Feb 11, 2026 |
| Feb 9, 2026 | Young Kwon director | AGrant or award Common Stock | +10,690 | $0.00 | $0 | 263,020 | Feb 11, 2026 |
| Feb 9, 2026 | Adam S Grossman President and CEO | AGrant or award Common Stock | +282,529 | $0.00 | $0 | 2,290,379 | Feb 11, 2026 |
| Feb 9, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | AGrant or award Common Stock | +91,631 | $0.00 | $0 | 580,321 | Feb 11, 2026 |
| Feb 9, 2026 | Jerrold B Grossman director | AGrant or award Common Stock | +10,690 | $0.00 | $0 | 488,884 | Feb 11, 2026 |
| Feb 9, 2026 | Eduardo Rene Salas director | AGrant or award Stock Option (Right to Buy)derivative | +17,730 | $0.00 | $0 | 17,730 | Feb 11, 2026 |
| Feb 9, 2026 | Alison Cecily Finger director | AGrant or award Stock Option (Right to Buy)derivative | +17,730 | $0.00 | $0 | 17,730 | Feb 11, 2026 |
| Feb 9, 2026 | Young Kwon director | AGrant or award Stock Option (Right to Buy)derivative | +17,730 | $0.00 | $0 | 17,730 | Feb 11, 2026 |
| Feb 9, 2026 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | AGrant or award Stock Option (right to buy)derivative | +144,230 | $0.00 | $0 | 144,230 | Feb 11, 2026 |
| Feb 9, 2026 | Steve Elms director | AGrant or award Stock Option (Right to Buy)derivative | +17,730 | $0.00 | $0 | 17,730 | Feb 11, 2026 |
| Feb 9, 2026 | Lawrence P. Guiheen director | AGrant or award Stock Option (Right to Buy)derivative | +17,730 | $0.00 | $0 | 17,730 | Feb 11, 2026 |
| Feb 9, 2026 | Adam S Grossman President and CEO | AGrant or award Stock Option (right to buy)derivative | +444,711 | $0.00 | $0 | 444,711 | Feb 11, 2026 |
| Feb 9, 2026 | Jerrold B Grossman director | AGrant or award Stock Option (Right to Buy)derivative | +17,730 | $0.00 | $0 | 17,730 | Feb 11, 2026 |
| Dec 15, 2025 | Adam S Grossman President and CEO | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,028,850 | Dec 16, 2025 |
| Dec 15, 2025 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -15,000 | $19.79 | $297k | 2,013,850 | Dec 16, 2025 |
| Dec 15, 2025 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -6,000 | $19.79 | $119k | 2,007,850 | Dec 16, 2025 |
| Dec 15, 2025 | Adam S Grossman President and CEO | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 720,950 | Dec 16, 2025 |
| Nov 19, 2025 | Adam S Grossman President and CEO | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,034,850 | Nov 21, 2025 |
| Nov 19, 2025 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -15,000 | $16.00 | $240k | 2,019,850 | Nov 21, 2025 |
| Nov 19, 2025 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -6,000 | $16.00 | $96k | 2,013,850 | Nov 21, 2025 |
| Nov 19, 2025 | Adam S Grossman President and CEO | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 735,950 | Nov 21, 2025 |
| Oct 24, 2025 | Adam S Grossman President and CEO | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,040,850 | Oct 24, 2025 |
| Oct 24, 2025 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -15,000 | $16.00 | $240k | 2,025,850 | Oct 24, 2025 |
| Oct 24, 2025 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -6,000 | $16.00 | $96k | 2,019,850 | Oct 24, 2025 |
| Oct 24, 2025 | Adam S Grossman President and CEO | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 750,950 | Oct 24, 2025 |
| Sep 15, 2025 | Adam S Grossman President and CEO | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,046,850 | Sep 16, 2025 |
| Sep 15, 2025 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -15,000 | $16.13 | $242k | 2,031,850 | Sep 16, 2025 |
| Sep 15, 2025 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -6,000 | $16.13 | $97k | 2,025,850 | Sep 16, 2025 |
| Sep 15, 2025 | Adam S Grossman President and CEO | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 765,950 | Sep 16, 2025 |
| Aug 15, 2025 | Adam S Grossman President and CEO | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,052,850 | Aug 15, 2025 |
| Aug 15, 2025 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -15,000 | $16.88 | $253k | 2,037,850 | Aug 15, 2025 |
| Aug 15, 2025 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -6,000 | $16.88 | $101k | 2,031,850 | Aug 15, 2025 |
| Aug 15, 2025 | Adam S Grossman President and CEO | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 780,950 | Aug 15, 2025 |
| Jul 30, 2025 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | MOption exercise Common Stock | +2,500 | $8.98 | $22k | 489,898 | Aug 1, 2025 |
| Jul 30, 2025 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | FTax withholding Common Stock | -1,208 | $18.59 | $22k | 488,690 | Aug 1, 2025 |
| Jul 30, 2025 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | MOption exercise Employee Stock Option (right to buy)derivative | -2,500 | $0.00 | $0 | 0 | Aug 1, 2025 |
| Jul 24, 2025 | Brad L. Tade CFO and Treasurer | FTax withholding Common Stock | -7,123 | $17.31 | $123k | 239,419 | Jul 28, 2025 |
| Jul 24, 2025 | Kaitlin M. Kestenberg-Messina COO and SVP, Compliance | FTax withholding Common Stock | -3,027 | $17.31 | $52k | 487,398 | Jul 28, 2025 |
| Jul 15, 2025 | Adam S Grossman President and CEO | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,058,850 | Jul 16, 2025 |
| Jul 15, 2025 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -15,000 | $18.66 | $280k | 2,043,850 | Jul 16, 2025 |
| Jul 15, 2025 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -6,000 | $18.66 | $112k | 2,037,850 | Jul 16, 2025 |
| Jul 15, 2025 | Adam S Grossman President and CEO | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 795,950 | Jul 16, 2025 |
| Jun 26, 2025 | Brad L. Tade CFO and Treasurer | FTax withholding Common Stock | -9,838 | $18.40 | $181k | 246,542 | Jun 30, 2025 |
| Jun 16, 2025 | Adam S Grossman President and CEO | MOption exercise Common Stock10b5-1 | +15,000 | $5.40 | $81k | 2,064,850 | Jun 18, 2025 |
| Jun 16, 2025 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -15,000 | $20.81 | $312k | 2,049,850 | Jun 18, 2025 |
| Jun 16, 2025 | Adam S Grossman President and CEO | SOpen-market sale Common Stock10b5-1 | -6,000 | $20.81 | $125k | 2,043,850 | Jun 18, 2025 |
| Jun 16, 2025 | Adam S Grossman President and CEO | MOption exercise Stock Option (right to buy)derivative10b5-1 | -15,000 | $0.00 | $0 | 810,950 | Jun 18, 2025 |
| Jun 12, 2025 | Steve Elms director | SOpen-market sale Common Stockindirect: See footnote | -92,941 | $21.69 | $2.0M | 2,031,730 | Jun 16, 2025 |
| Jun 13, 2025 | Steve Elms director | MOption exercise Common Stock | +9,000 | $5.96 | $54k | 96,330 | Jun 16, 2025 |
| Jun 13, 2025 | Steve Elms director | MOption exercise Common Stock | +10,000 | $5.00 | $50k | 106,330 | Jun 16, 2025 |
| Jun 13, 2025 | Steve Elms director | MOption exercise Common Stock | +53,837 | $3.66 | $197k | 160,167 | Jun 16, 2025 |
| Jun 13, 2025 | Steve Elms director | MOption exercise Common Stock | +17,500 | $4.91 | $86k | 177,667 | Jun 16, 2025 |
| Jun 13, 2025 | Steve Elms director | MOption exercise Common Stock | +30,000 | $3.89 | $117k | 207,667 | Jun 16, 2025 |
| Jun 13, 2025 | Steve Elms director | MOption exercise Common Stock | +15,000 | $2.92 | $44k | 222,667 | Jun 16, 2025 |
| Jun 13, 2025 | Steve Elms director | MOption exercise Common Stock | +55,000 | $2.35 | $129k | 277,667 | Jun 16, 2025 |
| Jun 13, 2025 | Steve Elms director | MOption exercise Common Stock | +53,172 | $1.67 | $89k | 330,839 | Jun 16, 2025 |
| Jun 13, 2025 | Steve Elms director | MOption exercise Common Stock | +51,630 | $3.35 | $173k | 382,469 | Jun 16, 2025 |
| Jun 13, 2025 | Steve Elms director | MOption exercise Common Stock | +37,541 | $5.40 | $203k | 420,010 | Jun 16, 2025 |
| Jun 13, 2025 | Steve Elms director | SOpen-market sale Common Stock | -137,931 | $20.82 | $2.9M | 282,079 | Jun 16, 2025 |
Insiders
Everyone who has filed a Form 4 here.
- Steve Elmsdirector
- Alison Cecily Fingerdirector
- Adam S GrossmanPresident and CEO
- Jerrold B Grossmandirector
- Lawrence P. Guiheendirector
- Young Kwondirector
- Kaitlin M. Kestenberg-MessinaCOO and SVP, Compliance
- Eduardo Rene Salasdirector
- Brad L. TadeCFO and Treasurer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.